宏達新材(002211.SZ)及子公司2021年度擬向商業銀行等金融機構申請綜合授信額度不超2億元
格隆匯 3 月 17日丨宏達新材(002211.SZ)公佈,根據公司及子公司資金預算及資金安全的需要,公司及子公司擬在2021年度內向商業銀行等金融機構申請綜合授信額度(包括但不限於流動資金貸款、併購貸款、信用證、承兑匯票等業務)總金額不超過人民幣2億元,以隨時滿足公司及子公司未來經營發展的融資要求。綜合授信額度最終以商業銀行等金融機構實際審批金額為準,在授權期限內,授信額度可循環使用。
向商業銀行等金融機構申請綜合授信額度符合公司及子公司的經營戰略及資金需求,有利於公司及子公司的長遠發展,不會對公司及子公司的生產經營產生不利影響,不會損害公司股東尤其是中小股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.